This case represents the most severe end-stage manifestation of hemophilic elbow arthropathy, with near-maximal structural damage and complete functional disability. The extensive destruction reflects seven decades of inadequate hemostatic control during an era without modern factor replacement therapy. Current management is entirely palliative as structural damage is irreversible. Maximal prophylaxis (FVIII 2500 IU three times weekly) primarily prevents new bleeding rather than improving function. Pain management requires multimodal approach including high-dose opioids (fentanyl patch 75mcg/72h, oxycodone 30mg four times daily), gabapentin 800mg three times daily, and topical therapies, though control remains inadequate. Surgical options are severely limited by age, multiple comorbidities (cirrhosis, HIV, CKD stage 4), poor bone quality, and uncertain benefit given complete ankylosis. Elbow arthrodesis has been discussed but offers minimal functional gain given fixed position already present. Total elbow arthroplasty is contraindicated due to severe bone loss and infection risk. Conservative management focuses on maintaining current state and preventing complications. Physical therapy is limited to pain modulation, positioning for comfort, and preventing skin breakdown. Occupational therapy provides adaptive equipment for activities of daily living performed by caregivers. Psychosocial support addresses severe depression and existential distress related to pain and disability. Quality of life is severely compromised with focus on palliative care principles. This case exemplifies the devastating consequences of hemophilia in the pre-prophylaxis era and underscores the transformative impact of modern comprehensive care in preventing such outcomes.

Mild distension synovitis olecranic recess elbow - severe hemophilia A